Clinical Trials Browser

Phase 2 × Lymphoma × orelabrutinib × Clear all

NCT07441993 2026-03-02

MZL-IIT-O

Phase 2 Recruiting

Lymphoma, Lymphoma, B-Cell, Marginal Zone

NCT07206264 2025-10-03

ADAPT-MCL

Phase 2 Not yet recruiting

Lymphoma, Lymphoma, Mantle-Cell